Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S B Howell

Showing results (121-130 of 260) with videos related to

Pageof 26
Sort By:
Cancer Research|December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell lineP Naredi, D D Heath, R E Enns, et al.
Cancer Treatment Reports|September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose scheduleT N Campbell, S B Howell, C Pfeifle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusionS Zimm, S M Cleary, C N Horton, et al.
Molecular Pharmacology|November 28, 2001
Identification of genes that mediate sensitivity to cisplatinH Niedner, R Christen, X Lin, et al.
The Journal of Clinical Investigation|March 1, 1995
Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cellsP Naredi, D D Heath, R E Enns, et al.
Cancer Drug Delivery|January 1, 1985
Maintenance of peritoneal catheter function by the intraperitoneal administration of 32% dextran 70C E Pfeifle, S B Howell, I S Abramson, et al.
Molecular Pharmacology|January 1, 1997
Role of determinants of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatinP Perego, J Vande Weghe, D W Ow, et al.
Cancer Research|March 1, 1980
Antitumor activity of L-canavanine against L1210 murine leukemiaM H Green, T L Brooks, J Mendelsohn, et al.
Molecular Pharmacology|November 28, 2000
p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxideX Lin, K Ramamurthi, M Mishima, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell lineR Jamshidipour, E B Pinho, D K Hom, et al.
Pageof 26

Showing results (121-130 of 260) with videos related to

Sort By:
Pageof 26
Cancer Research|December 15, 1994
Cross-resistance between cisplatin and antimony in a human ovarian carcinoma cell lineP Naredi, D D Heath, R E Enns, et al.
Cancer Treatment Reports|September 1, 1982
High-dose allopurinol modulation of 5-FU toxicity: phase I trial of an outpatient dose scheduleT N Campbell, S B Howell, C Pfeifle, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1988
Phase I/pharmacokinetic study of thioguanine administered as a 48-hour continuous intraperitoneal infusionS Zimm, S M Cleary, C N Horton, et al.
Molecular Pharmacology|November 28, 2001
Identification of genes that mediate sensitivity to cisplatinH Niedner, R Christen, X Lin, et al.
The Journal of Clinical Investigation|March 1, 1995
Cross-resistance between cisplatin, antimony potassium tartrate, and arsenite in human tumor cellsP Naredi, D D Heath, R E Enns, et al.
Cancer Drug Delivery|January 1, 1985
Maintenance of peritoneal catheter function by the intraperitoneal administration of 32% dextran 70C E Pfeifle, S B Howell, I S Abramson, et al.
Molecular Pharmacology|January 1, 1997
Role of determinants of cadmium sensitivity in the tolerance of Schizosaccharomyces pombe to cisplatinP Perego, J Vande Weghe, D W Ow, et al.
Cancer Research|March 1, 1980
Antitumor activity of L-canavanine against L1210 murine leukemiaM H Green, T L Brooks, J Mendelsohn, et al.
Molecular Pharmacology|November 28, 2000
p53 interacts with the DNA mismatch repair system to modulate the cytotoxicity and mutagenicity of hydrogen peroxideX Lin, K Ramamurthi, M Mishima, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1994
Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell lineR Jamshidipour, E B Pinho, D K Hom, et al.
Pageof 26